← All forecasts · November 2–6

AMD / FQ3 2026 (quarter ended 2026-09-26)

Advanced Micro Devices, Inc.

Reported: Nov 3, 2026

Forecast published

Opus 5.5 High in Shortcut

Review incomplete

Shortcut

1.96

Normalized diluted EPS

+1.3% vs Street

Off by $0.13 per share

Street

1.94

Normalized diluted EPS

November 1 consensus snapshot

Off by $0.15 per share

Real

2.09

Reported normalized EPS

Shortcut win

Reported result · Nov 3 ↗ · Provider normalized EPS 2.09 agrees with issuer non-GAAP diluted EPS 2.09; GAAP diluted EPS 1.46 is distinct.

USD per diluted ordinary/common share. Comparisons use unrounded estimates.

Model download

Explore the assumptions and calculations behind the forecast. This is the agent’s original workbook. Its review didn’t finish, so it hasn’t been checked or repaired.

Shortcut’s reasoning.

Guidance (4-Aug-2026): revenue $13.0B +/- $0.3B, non-GAAP GM ~56%, opex ~$3.65B, other income ~$55M, 13% tax, ~1.66B shares, implying ~$1.93 EPS.

AMD beat its revenue midpoint in each of the last six quarters (3.0-7.0%) and in 2026 beat its GM, opex-adjusted and other-income guides; model assumes a smaller +1.5% revenue beat ($13.2B).

Data Center $8.55B (+27% Q/Q) on server CPU strength (Intel DCAI +17% Q/Q, TSMC HPC +22% Q/Q) plus MI355 and first Helios rack shipments.

Client cut to $2.92B (-4.5% Q/Q) versus the guided slight growth because IDC PC units fell 9.1% Q/Q and Intel client revenue fell 9% Q/Q; Gaming -18%.

Result: non-GAAP EPS $1.965 vs $1.94 frozen consensus; P(beat) 70% after starting from 80% (size/history prior) and lowering for PC-market risk.

On the record.

Reporting period
FQ3 2026 (quarter ended 2026-09-26)
Reporting basis
non-GAAP diluted per common share, USD (AMD non-GAAP = normalized EPS)
Consensus snapshot
November 1, 2026
Model / effort
Opus 5.5 · High effort
Workbook
Original workbook · review incomplete
Record history
Forecast generated
Nov 1, 2026 at 10:54 PM PST
First posted
Nov 2, 2026 at 4:10 PM PST
Result checked
Nov 3, 2026 at 6:57 PM PST
Result basis

Provider normalized EPS 2.09 agrees with issuer non-GAAP diluted EPS 2.09; GAAP diluted EPS 1.46 is distinct. The literal issuer reconciliation retains all stated exclusions, including warrant remeasurement and tax adjustments. No rounded-equality or surprise backsolve is used.